Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID.
Neves RPL, Ammerlaan W, Andree KC, Bender S, Cayrefourcq L, Driemel C, Koch C, Luetke-Eversloh MV, Oulhen M, Rossi E, Alix-Panabières C, Betsou F, Farace F, Riethdorf S, Schlange T, Wikman H, Zamarchi R, Pantel K, Terstappen LWMM, Stoecklein NH; CANCER-ID Consortium. Neves RPL, et al. Among authors: farace f. Clin Chem. 2021 Mar 31;67(4):631-641. doi: 10.1093/clinchem/hvaa322. Clin Chem. 2021. PMID: 33491069
External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study.
Kraan J, Sleijfer S, Strijbos MH, Ignatiadis M, Peeters D, Pierga JY, Farace F, Riethdorf S, Fehm T, Zorzino L, Tibbe AG, Maestro M, Gisbert-Criado R, Denton G, de Bono JS, Dive C, Foekens JA, Gratama JW. Kraan J, et al. Among authors: farace f. Cytometry B Clin Cytom. 2011 Mar;80(2):112-8. doi: 10.1002/cyto.b.20573. Epub 2010 Nov 10. Cytometry B Clin Cytom. 2011. PMID: 21337491 Free article.
Circulating tumor cells in lung cancer.
Young R, Pailler E, Billiot F, Drusch F, Barthelemy A, Oulhen M, Besse B, Soria JC, Farace F, Vielh P. Young R, et al. Among authors: farace f. Acta Cytol. 2012;56(6):655-60. doi: 10.1159/000345182. Epub 2012 Nov 24. Acta Cytol. 2012. PMID: 23207444 Review.
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study.
Massard C, Oulhen M, Le Moulec S, Auger N, Foulon S, Abou-Lovergne A, Billiot F, Valent A, Marty V, Loriot Y, Fizazi K, Vielh P, Farace F. Massard C, et al. Among authors: farace f. Oncotarget. 2016 Aug 23;7(34):55069-55082. doi: 10.18632/oncotarget.10396. Oncotarget. 2016. PMID: 27391263 Free PMC article.
Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers.
Facchinetti F, Loriot Y, Kuo MS, Mahjoubi L, Lacroix L, Planchard D, Besse B, Farace F, Auger N, Remon J, Scoazec JY, André F, Soria JC, Friboulet L. Facchinetti F, et al. Among authors: farace f. Clin Cancer Res. 2016 Dec 15;22(24):5983-5991. doi: 10.1158/1078-0432.CCR-16-0917. Epub 2016 Jul 11. Clin Cancer Res. 2016. PMID: 27401242 Clinical Trial.
Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, Laplace-Builhé C, Besse B, Loriot Y, Ngo-Camus M, Hemanda M, Lindsay CR, Soria JC, Vielh P, Farace F. Pailler E, et al. Among authors: farace f. BMC Cancer. 2016 Jul 14;16:477. doi: 10.1186/s12885-016-2461-4. BMC Cancer. 2016. PMID: 27417942 Free PMC article.
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients.
Pailler E, Oulhen M, Borget I, Remon J, Ross K, Auger N, Billiot F, Ngo Camus M, Commo F, Lindsay CR, Planchard D, Soria JC, Besse B, Farace F. Pailler E, et al. Among authors: farace f. Cancer Res. 2017 May 1;77(9):2222-2230. doi: 10.1158/0008-5472.CAN-16-3072. Cancer Res. 2017. PMID: 28461563
130 results